Twice-Daily Budesonide Inhalation Suspension in Infants and Children <4 and ≥4 Years of Age with Persistent Asthma

REFERENCES

• Kemper K.J. Chronic Asthma: An Update. Pediatr. Rev. 1996; 17(4)111–118
   PubMedGoogle Scholar
• Mannino D., Homa D.M., Pertowski C.A., Ashizawa A., Nixon L.L., Johnson C.A., Ball L.B., Jack E., Kang D.S. Surveillance for Asthma—United States, 1960–1995. Mor. Mortal. Wkly. Rep. CDC Surveill. Summ. 1998; 47(1)1–27
   PubMedGoogle Scholar
• Burr M.L., Butland B.K., King S., Vaughan-Williams E. Changes in Asthma Prevalence: Two Surveys 15 Years Apart. Arch. Dis. Child. 1989; 64(10)1452–1456
   PubMedGoogle Scholar
• Yunginger J.W., Reed C.E., O’Connell E.J., Melton L.J., III, O’Fallon W.M., Silverstein M.D. A Community-Based Study of the Epidemiology of Asthma. Incidence Rates, 1964–1983. Am. Rev. Respir. Dis. 1992; 146(4)888–894
   PubMed Web of Science ®Google Scholar
• Barnes P.J. Current Issues for Establishing Inhaled Corticosteroids as the Antiinflammatory Agents of Choice in Asthma. J. Allergy Clin. Immunol. 1998; 101(4 Pt 2)S427–S433
   PubMed Web of Science ®Google Scholar
• National Asthma Education Program and Prevention Program. Expert Panel Report 2, Guidelines for the Diagnosis and Management of Asthma. NIH Publication No. 97-4051. National Heart, Lung, and Blood Institute, National Institutes of Health: Bethesda, MD, 1997
   Google Scholar
• Pediatric Asthma: Promoting Best Practice. Guide for Managing Asthma in Children. American Academy of Allergy, Asthma & Immunology, National Asthma Education and Prevention Program, National Heart, Lung, and Blood Institute, American Academy of Pediatrics, American Academy of Allergy, Asthma & Immunology Inc., Milwaukee, WI 1999
   Google Scholar
• Williams P.V. Management of Asthma. Clin. Symp. 1997; 49(3)1–32
   PubMedGoogle Scholar
• Baker J.W., Mellon M., Wald J., Welch M., Cruz-Rivera M., Walton-Bowen K. A Multiple-Dosing, Placebo-Controlled Study of Budesonide Inhalation Suspension Given Once or Twice Daily for Treatment of Persistent Asthma in Young Children and Infants. Pediatrics 1999; 103(2)414–421
   PubMed Web of Science ®Google Scholar
• Ilangovan P., Pedersen S., Godfrey S., Nikander K., Noviski N., Warner J.O. Treatment of Severe Steroid Dependent Preschool Asthma with Nebulised Budesonide Suspension. Arch. Dis. Child. 1993; 68(3)356–359
   PubMed Web of Science ®Google Scholar
• Vikre-Jørgensen J., Agertoft L., Pedersen S. Dose Titration of Nebulized Budesonide in Young Children. Pediatr. Pulmonol. 1997; 23(4)270–277
   PubMed Web of Science ®Google Scholar
• Volovitz B., Soferman R., Blau H., Nussinovitch M., Varsano I. Rapid Induction of Clinical Response with a Short-Term High-Dose Starting Schedule of Budesonide Nebulizing Suspension in Young Children with Recurrent Wheezing Episodes. J. Allergy Clin. Immunol. 1998; 101(4 Pt 1)464–469
   PubMed Web of Science ®Google Scholar
• Wennergren G., Nordvall S.L., Hedlin G., Möller C., Wille S., Åsbrink Nilsson E. Nebulized Budesonide for the Treatment of Moderate to Severe Asthma in Infants and Toddlers. Acta Paediatr. 1996; 85(2)183–189
   PubMed Web of Science ®Google Scholar
• Goodwin A. Treating Childhood Asthma with Nebulised Steroids. Prof. Care Mother Child 1995; 5(1)7–9
   PubMedGoogle Scholar
• Szefler S.J. Clinical Need for a Nebulized Corticosteroid. J. Allergy Clin. Immunol. 1999; 104(4 Pt 2)162–168
   PubMed Web of Science ®Google Scholar
• National Asthma Education Program. Expert Panel Report, Guidelines for the Diagnosis and Management of Asthma. NIH Publication No. 91-3042. National Heart, Lung, and Blood Institute, National Institutes of Health: Bethesda, MD, 1992
   Google Scholar
• Scott M.B., Ellis M.H., Cruz-Rivera M., Walton-Bowen K., Fitzpatrick S., Smith J.A. Once-Daily Budesonide Inhalation Suspension in Infants and Children < 4 and ≥ 4 Years of Age with Persistent Asthma. Ann. Allergy Asthma Immunol. 2001; 87: 488–489
   PubMed Web of Science ®Google Scholar
• de Blic J., Delacourt C., Le Bourgeois M., Mahut B., Ostinelli J., Caswell C., Scheinmann P. Efficacy of Nebulized Budesonide in Treatment of Severe Infantile Asthma: A Double-Blind Study. J. Allergy Clin. Immunol. 1996; 98(1)14–20
   PubMed Web of Science ®Google Scholar
• Shapiro G., Bronsky E.A., LaForce C.F., Mendelson L., Pearlman D., Schwartz R.H., Szefler S.J. Dose-Related Efficacy of Budesonide Administered Via a Dry Powder Inhaler in the Treatment of Children with Moderate to Severe Persistent Asthma. J. Pediatr. 1998; 132(6)976–982
   PubMed Web of Science ®Google Scholar
• Enarson D.A., Chretien J. Epidemiology of Respiratory Infectious Diseases. Curr. Opin. Pulm. Med. 1999; 5(3)128–135
   PubMedGoogle Scholar
• Bellanti J.A. Recurrent Respiratory Tract Infections in Paediatric Patients. Drugs. 1997; 54(suppl 1)1–4
   Google Scholar
• Tasche M.J.A., zan der Wouden J.C., Uijen J.H.J.M., Ponsioen B.P., Bernsen R.M., van Suijlekom-Smit L.W., de Jongste J.C. Randomised Placebo-Controlled Trial of Inhaled Sodium Cromoglycate in 1–4-Year-Old Children with Moderate Asthma. Lancet 1997; 350(9084)1060–1064
   PubMed Web of Science ®Google Scholar
• Price J.F., Weller P.H. Comparison of Fluticasone Propionate and Sodium Cromoglycate for the Treatment of Childhood Asthma (an Open Parallel Group Study). Respir. Med. 1995; 89(5)363–368
   PubMed Web of Science ®Google Scholar
• Kraemer R., Sennhauser F., Reinhardt M. Effects of Regular Inhalation of Beclomethasone Dipropionate and Sodium Cromoglycate on Bronchial Hyperreactivity in Asthmatic Children. Acta Pediatr. Scand. 1987; 76(1)119–123
   PubMed Web of Science ®Google Scholar